JELLI, B. et al. Complete Response to Afatinib of an EGFR Exon 18 delE709_T710insD-Mutated Stage IV Lung Adenocarcinoma. European Journal of Case Reports in Internal Medicine, v. 8, n. 8, 11 Aug.2021.